Auro Laboratories quarterly results and financials

Auro Laboratories (BSE 530233)₹228.35+0.33%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (standalone), Auro Laboratories reported sales of ₹9.81 Cr, up 32.7% from Mar 2025, and net profit of ₹0.96 Cr, up 152.6% year on year. For the year to Mar 2026, sales were ₹30.68 Cr and net profit ₹3.52 Cr.

Sales (Mar 2026): ₹9.81 Cr
Net profit (Mar 2026): ₹0.96 Cr
Sales (FY Mar 2026): ₹30.68 Cr
Net profit (FY Mar 2026): ₹3.52 Cr
EPS (Mar 2026): ₹1.55
Borrowings (Mar 2026): ₹63.24 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Auro Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Auro Laboratories Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	10.16	13.38	17.95	12.04	5.71	3.09	3.04	7.39	2.76	8.82	9.38	9.81
Expenses	8.99	10.35	13.85	9.61	4.38	2.37	2.59	6.57	2.73	6.47	5.31	6.48
Operating Profit	1.17	3.04	4.09	2.42	1.34	0.73	0.46	0.82	0.04	2.36	4.07	3.34
OPM %	11.4%	22.6%	22.7%	20.0%	23.3%	23.3%	14.8%	11.0%	1.1%	26.6%	43.3%	33.9%
Other Income	0.35	0.31	0.41	0.39	0.19	0.30	0.13	0.12	0.41	0.97	0.17	0.51
Interest	0.28	0.36	0.45	−0.33	0.26	0.29	0.26	0.31	0.29	0.97	1.53	1.50
Depreciation	0.26	0.26	0.26	0.27	0.26	0.26	0.26	0.28	0.26	0.64	0.97	0.89
Profit before tax	0.97	2.72	3.78	2.84	1.02	0.47	0.06	0.34	−0.11	1.71	1.75	1.45
Tax %	27.6%	27.9%	27.7%	18.7%	24.8%	25.1%	28.6%	−11.4%	0.0%	58.2%	−12.0%	32.9%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	0.70	1.96	2.72	2.31	0.74	0.35	0.04	0.38	−0.10	0.71	1.94	0.96
EPS (Rs)	1.13	3.15	4.37	3.71	1.19	0.57	0.07	0.62	−0.17	1.15	3.12	1.55

Auro Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Auro Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	27.87	35.42	40.71	46.78	43.77	54.18	50.77	52.83	53.53	19.11	30.68	30.77
Expenses	25.03	30.94	34.31	39.70	37.36	42.89	46.07	48.35	42.80	15.94	20.47	20.99
Operating Profit	2.81	4.45	6.37	7.00	6.29	11.25	4.64	4.40	10.69	3.14	10.22	9.81
OPM %	10.1%	12.6%	15.6%	15.0%	14.4%	20.8%	9.1%	8.3%	19.9%	16.4%	33.2%	31.9%
Other Income	0.41	0.52	0.50	0.95	0.96	0.75	1.08	0.93	1.49	0.92	1.65	2.06
Interest	1.67	1.19	1.22	0.88	0.59	0.47	0.84	0.82	0.75	1.09	4.26	4.29
Depreciation	0.67	0.85	0.92	1.00	1.01	1.03	1.01	1.06	1.08	1.09	2.80	2.76
Profit before tax	0.87	2.92	4.72	6.08	5.66	10.49	3.86	3.44	10.34	1.87	4.80	4.80
Tax %	0.0%	72.1%	25.2%	27.6%	28.0%	31.7%	26.6%	29.0%	24.7%	2.1%	26.7%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	0.87	0.81	3.52	4.39	4.04	7.17	2.83	2.43	7.78	1.83	3.52	3.51
EPS (Rs)	1.40	1.31	5.65	7.05	6.49	11.49	4.55	3.90	12.46	2.94	5.65	5.65
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Auro Laboratories balance sheet

₹ crore, at each year end.

Auro Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6.25	6.24	6.24	6.24	6.24	6.24	6.24	6.25	6.24	6.24	6.24	6.24
Reserves	1.48	2.36	3.19	6.77	11.21	15.32	22.43	25.37	28.07	35.85	36.85	40.22
Borrowings	16.44	12.60	4.94	9.18	8.07	3.15	3.15	13.78	6.40	26.19	44.89	63.24
Other Liabilities	4.69	4.51	12.46	8.26	8.01	7.69	10.17	9.71	15.40	17.45	11.05	11.48
Total Liabilities	28.86	25.71	26.83	30.45	33.53	32.40	41.99	55.11	56.11	85.73	99.03	121
Fixed Assets	9.81	9.12	12.99	13.01	14.58	14.25	13.55	13.60	12.61	22.14	21.07	75.22
CWIP	0.81	3.32	0.22	1.06	0.11	0.11	0.12	3.67	7.65	32.60	56.34	14.43
Investments	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.00
Other Assets	18.20	13.23	13.58	16.34	18.80	18.00	28.28	37.80	35.81	30.95	21.58	31.53
Inventories	5.58	4.32	1.34	1.50	3.38	4.07	2.56	4.24	11.77	8.25	3.68	13.55
Trade receivables	8.51	5.07	7.70	8.39	8.53	5.80	7.32	13.65	12.43	13.44	9.41	9.18
Cash & equivalents	0.45	0.54	1.02	2.26	4.12	5.69	14.57	12.42	2.43	1.66	0.64	1.68
Total Assets	28.86	25.71	26.83	30.45	33.53	32.40	41.99	55.11	56.11	85.73	99.03	121

Auro Laboratories cash flow

₹ crore, for each year.

Auro Laboratories Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−0.77	7.85	6.47	6.03	6.85	9.26	12.78	−6.57	3.27	18.74	5.01	2.10
Cash from investing activity	−0.72	−2.43	−2.19	−3.03	−3.18	−2.20	−3.50	−5.32	−5.07	−38.54	−23.61	−14.73
Cash from financing activity	0.52	−5.33	−3.80	−1.76	−1.82	−5.51	−0.45	9.77	−8.16	19.06	17.66	13.99
Net cash flow	−0.99	0.10	0.48	1.25	1.87	1.59	8.86	−2.15	−9.99	−0.78	−1.00	1.38
Capex	0.99	3.01	1.99	2.01	1.99	1.01	0.00	5.01	4.01	0.00	24.01	57.05
Free cash flow	−1.56	5.37	4.87	4.26	5.26	8.65	12.46	−11.22	−0.80	18.83	−18.82	−55.12
CFO / OP %	−26.9%	281.1%	146.1%	95.1%	98.1%	148.1%	114.1%	−141.9%	75.1%	176.1%	184.1%	21.1%

Auro Laboratories ratios

Working-capital days and returns, by year.

Auro Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	95	66	79	75	66	48	49	98	86	91	179	109
Inventory days	89	87	22	22	43	61	33	47	120	113	145	816
Days payable	57	73	81	79	67	72	75	55	118	86	247	283
Cash conversion cycle	129	82	22	20	44	39	9	92	89	120	80	643
Working capital days	39	27	67	65	63	51	29	37	104	36	−27	6
ROCE %	10.7%	11.2%	23.0%	32.5%	29.1%	24.8%	38.9%	12.2%	9.9%	20.4%	3.8%	9.5%

Auro Laboratories: frequently asked questions

What are the latest quarterly results of Auro Laboratories?

For the Mar 2026 quarter, Auro Laboratories reported sales of ₹9.81 Cr, up 32.7% year on year and net profit of ₹0.96 Cr, up 152.6% year on year. The operating margin was 33.9%.

What is the annual revenue of Auro Laboratories?

Auro Laboratories' sales for the year to Mar 2026 were ₹30.68 Cr; over the last twelve months they were ₹30.77 Cr.

What is the net profit of Auro Laboratories?

Net profit for the year to Mar 2026 was ₹3.52 Cr, and ₹3.51 Cr over the last twelve months. Earnings per share over the same trailing period were ₹5.65.

How much debt does Auro Laboratories have?

Auro Laboratories reported borrowings of ₹63.24 Cr at Mar 2026, against cash and equivalents of ₹1.68 Cr.

What is the free cash flow of Auro Laboratories?

Cash from operations was ₹2.10 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹55.12 Cr.

Loading…